Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Tianjin Anding Hospital

Home Clinical Trial Sponsors and OrganizationsTianjin Anding Hospital

Tianjin Anding Hospital

No.13, Liulin Rd., Hexi Dist., Tianjin, China

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

23

6 active

Approvals

0

Total approvals

Agencies

0

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Not Applicable

15

65.2%

Phase 4

1

4.3%

Trial Status Distribution

Completed

7

30.4%

Enrolling By Invitation

4

17.4%

Not yet recruiting

2

8.7%

Recruiting

5

21.7%

Unknown

5

21.7%

Clinical Trials

Trials sponsored by this organization (23)

PQQ for Cognitive and Negative Symptoms

Not yet recruiting

Feb 202670 participants

Investigation on Suicide Risk Factors of Patients With Mood Disorders

Dec 2025300 participants

TACS on High-inflammatory and Refractory Depression

Jan 202552 participants

Efficacy, Tolerability, and Cognitive Effects of Deep Transcranial Magnetic Stimulation for Bipolar Depression

Aug 2024100 participants

Tryptophan-Kynurenine Pathway Metabolism in the Pathophysiology of Cognitive Impairment in Schizophrenia.

Enrolling By Invitation

Feb 2024200 participants

Berberine in Treating Negative Symptoms of Schizophrenia: Clinical Efficacy and Mechanisms

Enrolling By Invitation

Sep 2023120 participants

Berberine Improving Cognitive Impairments in Schizophrenia

Jul 2023124 participants

Exosome for Early Diagnosis of Bipolar Affective Disorder

Not yet recruiting

Jun 2023130 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

On this page

Overview
Clinical Trials23
Approvals
News

Back to Organizations